MiR-302A-loaded UC-MSCs-Exo was reported to suppress the proliferation and migration of endometrial cancer cells by inhibiting the expression of cyclin D1 and the AKT signalling pathway during endometrial cancer treatment (114). Here, CCND1 is linked to endometrial cancer.